IFM Therapeutics

IFM Therapeutics (IFM) is a biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing therapies that modulate novel targets in the innate immune system. The company was founded by a group of distinguished scientists and physicians who have spent decades understanding the innate immune system and its role in regulating the immune system. IFM’s team has discovered and developed small molecules that modulate new targets within the innate immune system as next-generation therapies for cancer, autoimmune, and inflammatory diseases.